Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural modifications of antisense oligonucleotides.

Ernst Urban1, Christian R Noe

  • 1Institut für Pharmazeutische Chemie, Universität Wien, Pharmaziezentrum, Althanstrasse 14, 1090 Wien, Austria.

Farmaco (Societa Chimica Italiana : 1989)
|March 7, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Total Synthesis of (15R)- and (15S)-Prostaglandin A<sub>2</sub>.

Chemistry (Weinheim an der Bergstrasse, Germany)·2024
Same author

Design, synthesis, and lead optimization of piperazinyl-pyrimidine analogues as potent small molecules targeting the viral capping machinery of Chikungunya virus.

European journal of medicinal chemistry·2023
Same author

Chirality Matters: Fine-Tuning of Novel Monoamine Reuptake Inhibitors Selectivity through Manipulation of Stereochemistry.

Biomolecules·2023
Same author

miRNA-132/212 Deficiency Disrupts Selective Corticosterone Modulation of Dorsal vs. Ventral Hippocampal Metaplasticity.

International journal of molecular sciences·2023
Same author

Low-Affinity/High-Selectivity Dopamine Transport Inhibition Sufficient to Rescue Cognitive Functions in the Aging Rat.

Biomolecules·2023
Same author

Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen.

Pharmaceutics·2022
Same journal

Chemical and biochemical transformations of 5-ethoxycarbonyl-5-phenyl-2-isoxazolines.

Farmaco (Societa chimica italiana : 1989)·2005
Same journal

Nasal administration of heparin-loaded microspheres based on poly(lactic acid).

Farmaco (Societa chimica italiana : 1989)·2005
Same journal

New 8-substituted xanthiene derivatives as potent bronchodilators.

Farmaco (Societa chimica italiana : 1989)·2005
Same journal

In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.

Farmaco (Societa chimica italiana : 1989)·2005
Same journal

Synthesis of 3-aryl-5-decapentyl-1,2,4-oxadiazoles possessing antiinflammatory and antitumor properties.

Farmaco (Societa chimica italiana : 1989)·2005
Same journal

Syntheses, in vitro antibacterial and antifungal activities of a series of N-alkyl, 1,4-dithiines.

Farmaco (Societa chimica italiana : 1989)·2005
See all related articles

Antisense oligonucleotides offer targeted gene silencing. Advances in chemical modifications have led to more stable and effective antisense drugs, including novel oligonucleotide designs for enhanced therapeutic applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Drug Discovery

Background:

  • Antisense oligonucleotides (ASOs) inhibit gene expression via sequence-specific mRNA targeting.
  • Natural oligonucleotides exhibit rapid degradation in vivo, limiting therapeutic use.
  • Chemical modifications enhance stability and efficacy of ASOs against degradation.

Purpose of the Study:

  • To review the evolution and advancements in antisense oligonucleotide technology.
  • To highlight key generations of ASOs and their improved properties.
  • To explore emerging applications and novel designs in antisense research.

Main Methods:

  • Review of literature on antisense oligonucleotide development and applications.
  • Analysis of chemical modifications and their impact on stability and efficacy.

Related Experiment Videos

  • Discussion of different generations of ASOs, including second and third generation designs.

    • Main Results:

    • First-generation ASOs (e.g., Fomivirsene) demonstrated therapeutic potential via phosphate linkage modification.
    • Second-generation ASOs with 2'-alkoxy substituents show enhanced stability against nucleases.
    • Third-generation ASOs, including zwitterionic designs, offer increased stability and reduced non-specific binding.
    • Oligonucleotide chimäres with functional moieties show promise for enhanced action and detection.

    Conclusions:

    • Chemical modifications are crucial for developing stable and effective antisense oligonucleotides.
    • Progress in ASO technology has led to improved therapeutic candidates and novel applications.
    • Future research focuses on advanced designs like oligonucleotide chimäres for enhanced gene silencing and diagnostics.